Centene Corp vs Synopsys, Inc. — how do they compare? Centene Corp trades at $66.33 (market cap $32.89B), while Synopsys, Inc. trades at $410.9 (market cap $78.83B). The key difference: Synopsys, Inc. is far larger — about 2.4× Centene Corp's market cap, and Centene Corp is trading nearer its 52-week high, Synopsys, Inc. nearer its low. Which is the better fit depends on your goals.
| CNC | SNPS | |
|---|---|---|
Market Cap | $32.89B | $78.83B |
Sector | Health | Technology |
52-Week High | $68.72 | $625.80 |
52-Week Low | $26.17 | $372.33 |
Enterprise Value | $21.93B | $87.19B |
Trailing returns across standard periods
Latest headlines on both assets
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →